Eratia

Medicinal product

(Invented) name

Eratia

Active substance (s)

Piperacilinas/Tazobaktamas

Strength

4000 mg/500 mg

Pharmaceutical form

milteliai infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01CR05, Piperacillin and beta-lactamase inhibitor

Marketing authorisation holder

Medochemie Ltd., Kipras

Date of authorisation

2026-04-20

Date of renewal

Documents

5412,6004_Eratia.docx

5412,6004_pakuotes lapelis_2026-04-10.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/5451/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Flakone yra	1 vnt.
Piperacilinas	4000 mg
Tazobaktamas	500 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
120553	106657	1106657	flakonas	N1		Receptinis	LT/1/26/6004/001	Netiekiama	-	-	No	-	-
120554	106658	1106658	flakonas	N4		Receptinis	LT/1/26/6004/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-04-20	Registruotas